CUFENCE

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Lithuania, Poland, United Kingdom

Active ingredients

The drug CUFENCE contains one active pharmaceutical ingredient (API):

1 Trientine UNII HC3NX54582 - TRIENTINE HYDROCHLORIDE

Trientine is a copper-chelating agent whose principal mechanism of action is to eliminate absorbed copper from the body by forming a stable complex that is then eliminated through urinary excretion. Trientine may also chelate copper in the intestinal tract and so inhibit copper absorption. Read about Trientine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AX12		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AX Various alimentary tract and metabolism products
Discover more medicines within A16AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1800021
Country: FR	Base de données publique des médicaments	Identifier(s): 65919229
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 390459
Country: IE	Health Products Regulatory Authority	Identifier(s): 89011
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1088312
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100427110